Industry Research Reports

Home > Reports > Pharma & Healthcare > Immune Adjuvant - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Immune Adjuvant - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-13

Pages: 120 Pages

Report ld: 2630328

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

The global market for Immune Adjuvant was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Immune Adjuvant was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Immune Adjuvant was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Immune Adjuvant was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Immune Adjuvant include SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue and Aphios, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Immune Adjuvant, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Immune Adjuvant by region & country, by Type, and by Application.

The Immune Adjuvant market size, estimations, and forecasts are provided in terms of sales volume (KG) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Adjuvant.

Market Segmentation

Report Metric
Details
Report Title
Immune Adjuvant - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Immune Adjuvant Companies Covered
SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue, Aphios, GSK, CSL Limited, Brenntag Biosector, Abace, Avanti Polar Lipids
Global Immune Adjuvant Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immune Adjuvant Market, Segment by Type
Freund's Adjuvant

Cytokine Adjuvants
Global Immune Adjuvant Market, Segment by Application
Research

Commercial
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Immune Adjuvant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Immune Adjuvant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Immune Adjuvant in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Immune Adjuvant Product Introduction
    1.2 Global Immune Adjuvant Market Size Forecast
        1.2.1 Global Immune Adjuvant Sales Value (2019-2030)
        1.2.2 Global Immune Adjuvant Sales Volume (2019-2030)
        1.2.3 Global Immune Adjuvant Sales Price (2019-2030)
    1.3 Immune Adjuvant Market Trends & Drivers
        1.3.1 Immune Adjuvant Industry Trends
        1.3.2 Immune Adjuvant Market Drivers & Opportunity
        1.3.3 Immune Adjuvant Market Challenges
        1.3.4 Immune Adjuvant Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Immune Adjuvant Players Revenue Ranking (2023)
    2.2 Global Immune Adjuvant Revenue by Company (2019-2024)
    2.3 Global Immune Adjuvant Players Sales Volume Ranking (2023)
    2.4 Global Immune Adjuvant Sales Volume by Company Players (2019-2024)
    2.5 Global Immune Adjuvant Average Price by Company (2019-2024)
    2.6 Key Manufacturers Immune Adjuvant Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Immune Adjuvant Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Immune Adjuvant
    2.9 Immune Adjuvant Market Competitive Analysis
        2.9.1 Immune Adjuvant Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Immune Adjuvant Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Adjuvant as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Freund's Adjuvant
        3.1.2 Cytokine Adjuvants
    3.2 Global Immune Adjuvant Sales Value by Type
        3.2.1 Global Immune Adjuvant Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Immune Adjuvant Sales Value, by Type (2019-2030)
        3.2.3 Global Immune Adjuvant Sales Value, by Type (%) (2019-2030)
    3.3 Global Immune Adjuvant Sales Volume by Type
        3.3.1 Global Immune Adjuvant Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Immune Adjuvant Sales Volume, by Type (2019-2030)
        3.3.3 Global Immune Adjuvant Sales Volume, by Type (%) (2019-2030)
    3.4 Global Immune Adjuvant Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Research
        4.1.2 Commercial
    4.2 Global Immune Adjuvant Sales Value by Application
        4.2.1 Global Immune Adjuvant Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Immune Adjuvant Sales Value, by Application (2019-2030)
        4.2.3 Global Immune Adjuvant Sales Value, by Application (%) (2019-2030)
    4.3 Global Immune Adjuvant Sales Volume by Application
        4.3.1 Global Immune Adjuvant Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Immune Adjuvant Sales Volume, by Application (2019-2030)
        4.3.3 Global Immune Adjuvant Sales Volume, by Application (%) (2019-2030)
    4.4 Global Immune Adjuvant Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Immune Adjuvant Sales Value by Region
        5.1.1 Global Immune Adjuvant Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Immune Adjuvant Sales Value by Region (2019-2024)
        5.1.3 Global Immune Adjuvant Sales Value by Region (2025-2030)
        5.1.4 Global Immune Adjuvant Sales Value by Region (%), (2019-2030)
    5.2 Global Immune Adjuvant Sales Volume by Region
        5.2.1 Global Immune Adjuvant Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Immune Adjuvant Sales Volume by Region (2019-2024)
        5.2.3 Global Immune Adjuvant Sales Volume by Region (2025-2030)
        5.2.4 Global Immune Adjuvant Sales Volume by Region (%), (2019-2030)
    5.3 Global Immune Adjuvant Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Immune Adjuvant Sales Value, 2019-2030
        5.4.2 North America Immune Adjuvant Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Immune Adjuvant Sales Value, 2019-2030
        5.5.2 Europe Immune Adjuvant Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Immune Adjuvant Sales Value, 2019-2030
        5.6.2 Asia Pacific Immune Adjuvant Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Immune Adjuvant Sales Value, 2019-2030
        5.7.2 South America Immune Adjuvant Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Immune Adjuvant Sales Value, 2019-2030
        5.8.2 Middle East & Africa Immune Adjuvant Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Immune Adjuvant Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Immune Adjuvant Sales Value
        6.2.1 Key Countries/Regions Immune Adjuvant Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Immune Adjuvant Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Immune Adjuvant Sales Value, 2019-2030
        6.3.2 United States Immune Adjuvant Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Immune Adjuvant Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Immune Adjuvant Sales Value, 2019-2030
        6.4.2 Europe Immune Adjuvant Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Immune Adjuvant Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Immune Adjuvant Sales Value, 2019-2030
        6.5.2 China Immune Adjuvant Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Immune Adjuvant Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Immune Adjuvant Sales Value, 2019-2030
        6.6.2 Japan Immune Adjuvant Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Immune Adjuvant Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Immune Adjuvant Sales Value, 2019-2030
        6.7.2 South Korea Immune Adjuvant Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Immune Adjuvant Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Immune Adjuvant Sales Value, 2019-2030
        6.8.2 Southeast Asia Immune Adjuvant Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Immune Adjuvant Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Immune Adjuvant Sales Value, 2019-2030
        6.9.2 India Immune Adjuvant Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Immune Adjuvant Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 SEPPIC
        7.1.1 SEPPIC Company Information
        7.1.2 SEPPIC Introduction and Business Overview
        7.1.3 SEPPIC Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 SEPPIC Immune Adjuvant Product Offerings
        7.1.5 SEPPIC Recent Development
    7.2 SDA BIO
        7.2.1 SDA BIO Company Information
        7.2.2 SDA BIO Introduction and Business Overview
        7.2.3 SDA BIO Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 SDA BIO Immune Adjuvant Product Offerings
        7.2.5 SDA BIO Recent Development
    7.3 Croda International Plc
        7.3.1 Croda International Plc Company Information
        7.3.2 Croda International Plc Introduction and Business Overview
        7.3.3 Croda International Plc Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Croda International Plc Immune Adjuvant Product Offerings
        7.3.5 Croda International Plc Recent Development
    7.4 SPI Pharma
        7.4.1 SPI Pharma Company Information
        7.4.2 SPI Pharma Introduction and Business Overview
        7.4.3 SPI Pharma Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 SPI Pharma Immune Adjuvant Product Offerings
        7.4.5 SPI Pharma Recent Development
    7.5 Phibro Animal Health Corporation
        7.5.1 Phibro Animal Health Corporation Company Information
        7.5.2 Phibro Animal Health Corporation Introduction and Business Overview
        7.5.3 Phibro Animal Health Corporation Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Phibro Animal Health Corporation Immune Adjuvant Product Offerings
        7.5.5 Phibro Animal Health Corporation Recent Development
    7.6 Tj Kaiwei
        7.6.1 Tj Kaiwei Company Information
        7.6.2 Tj Kaiwei Introduction and Business Overview
        7.6.3 Tj Kaiwei Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Tj Kaiwei Immune Adjuvant Product Offerings
        7.6.5 Tj Kaiwei Recent Development
    7.7 Novavax
        7.7.1 Novavax Company Information
        7.7.2 Novavax Introduction and Business Overview
        7.7.3 Novavax Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Novavax Immune Adjuvant Product Offerings
        7.7.5 Novavax Recent Development
    7.8 Zhuoyue
        7.8.1 Zhuoyue Company Information
        7.8.2 Zhuoyue Introduction and Business Overview
        7.8.3 Zhuoyue Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Zhuoyue Immune Adjuvant Product Offerings
        7.8.5 Zhuoyue Recent Development
    7.9 Aphios
        7.9.1 Aphios Company Information
        7.9.2 Aphios Introduction and Business Overview
        7.9.3 Aphios Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Aphios Immune Adjuvant Product Offerings
        7.9.5 Aphios Recent Development
    7.10 GSK
        7.10.1 GSK Company Information
        7.10.2 GSK Introduction and Business Overview
        7.10.3 GSK Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 GSK Immune Adjuvant Product Offerings
        7.10.5 GSK Recent Development
    7.11 CSL Limited
        7.11.1 CSL Limited Company Information
        7.11.2 CSL Limited Introduction and Business Overview
        7.11.3 CSL Limited Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 CSL Limited Immune Adjuvant Product Offerings
        7.11.5 CSL Limited Recent Development
    7.12 Brenntag Biosector
        7.12.1 Brenntag Biosector Company Information
        7.12.2 Brenntag Biosector Introduction and Business Overview
        7.12.3 Brenntag Biosector Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Brenntag Biosector Immune Adjuvant Product Offerings
        7.12.5 Brenntag Biosector Recent Development
    7.13 Abace
        7.13.1 Abace Company Information
        7.13.2 Abace Introduction and Business Overview
        7.13.3 Abace Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        7.13.4 Abace Immune Adjuvant Product Offerings
        7.13.5 Abace Recent Development
    7.14 Avanti Polar Lipids
        7.14.1 Avanti Polar Lipids Company Information
        7.14.2 Avanti Polar Lipids Introduction and Business Overview
        7.14.3 Avanti Polar Lipids Immune Adjuvant Sales, Revenue and Gross Margin (2019-2024)
        7.14.4 Avanti Polar Lipids Immune Adjuvant Product Offerings
        7.14.5 Avanti Polar Lipids Recent Development

 8 Industry Chain Analysis
    8.1 Immune Adjuvant Industrial Chain
    8.2 Immune Adjuvant Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Immune Adjuvant Sales Model
        8.5.2 Sales Channel
        8.5.3 Immune Adjuvant Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Immune Adjuvant Market Trends
    Table 2. Immune Adjuvant Market Drivers & Opportunity
    Table 3. Immune Adjuvant Market Challenges
    Table 4. Immune Adjuvant Market Restraints
    Table 5. Global Immune Adjuvant Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Immune Adjuvant Revenue Market Share by Company (2019-2024)
    Table 7. Global Immune Adjuvant Sales Volume by Company (2019-2024) & (KG)
    Table 8. Global Immune Adjuvant Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Immune Adjuvant Price by Company (2019-2024) & (US$/KG)
    Table 10. Key Manufacturers Immune Adjuvant Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Immune Adjuvant Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Immune Adjuvant
    Table 13. Global Immune Adjuvant Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Adjuvant as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Immune Adjuvant Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Immune Adjuvant Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Immune Adjuvant Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Immune Adjuvant Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Immune Adjuvant Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Immune Adjuvant Sales Volume by Type: 2019 VS 2023 VS 2030 (KG)
    Table 22. Global Immune Adjuvant Sales Volume by Type (2019-2024) & (KG)
    Table 23. Global Immune Adjuvant Sales Volume by Type (2025-2030) & (KG)
    Table 24. Global Immune Adjuvant Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Immune Adjuvant Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Immune Adjuvant Price by Type (2019-2024) & (US$/KG)
    Table 27. Global Immune Adjuvant Price by Type (2025-2030) & (US$/KG)
    Table 28. Global Immune Adjuvant Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Immune Adjuvant Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Immune Adjuvant Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Immune Adjuvant Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Immune Adjuvant Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Immune Adjuvant Sales Volume by Application: 2019 VS 2023 VS 2030 (KG)
    Table 34. Global Immune Adjuvant Sales Volume by Application (2019-2024) & (KG)
    Table 35. Global Immune Adjuvant Sales Volume by Application (2025-2030) & (KG)
    Table 36. Global Immune Adjuvant Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Immune Adjuvant Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Immune Adjuvant Price by Application (2019-2024) & (US$/KG)
    Table 39. Global Immune Adjuvant Price by Application (2025-2030) & (US$/KG)
    Table 40. Global Immune Adjuvant Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Immune Adjuvant Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Immune Adjuvant Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Immune Adjuvant Sales Value by Region (2019-2024) & (%)
    Table 44. Global Immune Adjuvant Sales Value by Region (2025-2030) & (%)
    Table 45. Global Immune Adjuvant Sales Volume by Region (KG): 2019 VS 2023 VS 2030
    Table 46. Global Immune Adjuvant Sales Volume by Region (2019-2024) & (KG)
    Table 47. Global Immune Adjuvant Sales Volume by Region (2025-2030) & (KG)
    Table 48. Global Immune Adjuvant Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Immune Adjuvant Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Immune Adjuvant Average Price by Region (2019-2024) & (US$/KG)
    Table 51. Global Immune Adjuvant Average Price by Region (2025-2030) & (US$/KG)
    Table 52. Key Countries/Regions Immune Adjuvant Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Immune Adjuvant Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Immune Adjuvant Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Immune Adjuvant Sales Volume, (2019-2024) & (KG)
    Table 56. Key Countries/Regions Immune Adjuvant Sales Volume, (2025-2030) & (KG)
    Table 57. SEPPIC Company Information
    Table 58. SEPPIC Introduction and Business Overview
    Table 59. SEPPIC Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 60. SEPPIC Immune Adjuvant Product Offerings
    Table 61. SEPPIC Recent Development
    Table 62. SDA BIO Company Information
    Table 63. SDA BIO Introduction and Business Overview
    Table 64. SDA BIO Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 65. SDA BIO Immune Adjuvant Product Offerings
    Table 66. SDA BIO Recent Development
    Table 67. Croda International Plc Company Information
    Table 68. Croda International Plc Introduction and Business Overview
    Table 69. Croda International Plc Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 70. Croda International Plc Immune Adjuvant Product Offerings
    Table 71. Croda International Plc Recent Development
    Table 72. SPI Pharma Company Information
    Table 73. SPI Pharma Introduction and Business Overview
    Table 74. SPI Pharma Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 75. SPI Pharma Immune Adjuvant Product Offerings
    Table 76. SPI Pharma Recent Development
    Table 77. Phibro Animal Health Corporation Company Information
    Table 78. Phibro Animal Health Corporation Introduction and Business Overview
    Table 79. Phibro Animal Health Corporation Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 80. Phibro Animal Health Corporation Immune Adjuvant Product Offerings
    Table 81. Phibro Animal Health Corporation Recent Development
    Table 82. Tj Kaiwei Company Information
    Table 83. Tj Kaiwei Introduction and Business Overview
    Table 84. Tj Kaiwei Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 85. Tj Kaiwei Immune Adjuvant Product Offerings
    Table 86. Tj Kaiwei Recent Development
    Table 87. Novavax Company Information
    Table 88. Novavax Introduction and Business Overview
    Table 89. Novavax Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 90. Novavax Immune Adjuvant Product Offerings
    Table 91. Novavax Recent Development
    Table 92. Zhuoyue Company Information
    Table 93. Zhuoyue Introduction and Business Overview
    Table 94. Zhuoyue Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 95. Zhuoyue Immune Adjuvant Product Offerings
    Table 96. Zhuoyue Recent Development
    Table 97. Aphios Company Information
    Table 98. Aphios Introduction and Business Overview
    Table 99. Aphios Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 100. Aphios Immune Adjuvant Product Offerings
    Table 101. Aphios Recent Development
    Table 102. GSK Company Information
    Table 103. GSK Introduction and Business Overview
    Table 104. GSK Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 105. GSK Immune Adjuvant Product Offerings
    Table 106. GSK Recent Development
    Table 107. CSL Limited Company Information
    Table 108. CSL Limited Introduction and Business Overview
    Table 109. CSL Limited Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 110. CSL Limited Immune Adjuvant Product Offerings
    Table 111. CSL Limited Recent Development
    Table 112. Brenntag Biosector Company Information
    Table 113. Brenntag Biosector Introduction and Business Overview
    Table 114. Brenntag Biosector Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 115. Brenntag Biosector Immune Adjuvant Product Offerings
    Table 116. Brenntag Biosector Recent Development
    Table 117. Abace Company Information
    Table 118. Abace Introduction and Business Overview
    Table 119. Abace Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 120. Abace Immune Adjuvant Product Offerings
    Table 121. Abace Recent Development
    Table 122. Avanti Polar Lipids Company Information
    Table 123. Avanti Polar Lipids Introduction and Business Overview
    Table 124. Avanti Polar Lipids Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 125. Avanti Polar Lipids Immune Adjuvant Product Offerings
    Table 126. Avanti Polar Lipids Recent Development
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Immune Adjuvant Downstream Customers
    Table 130. Immune Adjuvant Distributors List
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Immune Adjuvant Product Picture
    Figure 2. Global Immune Adjuvant Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Immune Adjuvant Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Immune Adjuvant Sales Volume (2019-2030) & (KG)
    Figure 5. Global Immune Adjuvant Sales Price (2019-2030) & (US$/KG)
    Figure 6. Immune Adjuvant Report Years Considered
    Figure 7. Global Immune Adjuvant Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Immune Adjuvant Players Sales Volume Ranking (2023) & (KG)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Immune Adjuvant Revenue in 2023
    Figure 10. Immune Adjuvant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Freund's Adjuvant Picture
    Figure 12. Cytokine Adjuvants Picture
    Figure 13. Global Immune Adjuvant Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Immune Adjuvant Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Immune Adjuvant Sales Volume by Type (2019 VS 2023 VS 2030) & (KG)
    Figure 16. Global Immune Adjuvant Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Immune Adjuvant Price by Type (2019-2030) & (US$/KG)
    Figure 18. Product Picture of Research
    Figure 19. Product Picture of Commercial
    Figure 20. Global Immune Adjuvant Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Immune Adjuvant Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Immune Adjuvant Sales Volume by Application (2019 VS 2023 VS 2030) & (KG)
    Figure 23. Global Immune Adjuvant Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Immune Adjuvant Price by Application (2019-2030) & (US$/KG)
    Figure 25. North America Immune Adjuvant Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Immune Adjuvant Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Immune Adjuvant Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Immune Adjuvant Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Immune Adjuvant Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Immune Adjuvant Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Immune Adjuvant Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Immune Adjuvant Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Immune Adjuvant Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Immune Adjuvant Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Immune Adjuvant Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Immune Adjuvant Sales Volume (%), (2019-2030)
    Figure 37. United States Immune Adjuvant Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Immune Adjuvant Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Immune Adjuvant Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Immune Adjuvant Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Immune Adjuvant Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Immune Adjuvant Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Immune Adjuvant Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Immune Adjuvant Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Immune Adjuvant Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Immune Adjuvant Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Immune Adjuvant Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Immune Adjuvant Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Immune Adjuvant Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Immune Adjuvant Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Immune Adjuvant Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Immune Adjuvant Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Immune Adjuvant Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Immune Adjuvant Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Immune Adjuvant Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Immune Adjuvant Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Immune Adjuvant Sales Value by Application (%), 2023 VS 2030
    Figure 58. Immune Adjuvant Industrial Chain
    Figure 59. Immune Adjuvant Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed

The global market for Immune Adjuvant was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Immune Adjuvant was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Immune Adjuvant was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Immune Adjuvant was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Immune Adjuvant include SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue and Aphios, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Immune Adjuvant, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Immune Adjuvant by region & country, by Type, and by Application.

The Immune Adjuvant market size, estimations, and forecasts are provided in terms of sales volume (KG) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Adjuvant.

Market Segmentation

Industry: Pharma & Healthcare

Published: 2024-01-13

Pages: 120 Pages

Report ld: 2630328

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3950.00

Multi Users License

USD 5925.00

Corporate Users License